1. 1. T. E. Assafa, S. Nandi, D. Śmiłowicz, L. Galazzo, M. Teucher, C. Elsner, S. Pütz, S. Bleicken, A. Y. Robin, D. Westphal, I. Uson, R. Stoll, P. E. Czabotar, N. Metzler-Nolte, E. Bordignon. Biophysical Characterization of Pro-apoptotic BimBH3 Peptides Reveals an Unexpected Capacity for Self-Association

      Structure, vol. 29, 2021, pp. 114-124.e3

       

   2. H. Baudhuin, P. J. Van Bockstal, T. De Beer, I. Vaneycken, J. Bridoux, G. Raes, V. Caveliers, M. Keyaerts, N. Devoogdt, T. Lahoutte, C. Xavier. Lyophilization of NOTA-sdAbs: First step towards a cold diagnostic kit for ⁶⁸Ga-labeling

      Eur J Pharm Biopharm, vol. 166, 2021, pp. 194-204

       

   3. I. J. G. Burvenich, Y. W. Goh, N. Guo, H. K. Gan, A. Rigopoulos, D. Cao, Z. Liu, U. Ackermann, C. W. Wichmann, A. F. McDonald, N. Huynh, G. J. O\’Keefe, S. J. Gong, F. E. Scott, L. Li, W. Geng, A. Zutshi, Y. Lan, A. M. Scott. Radiolabelling and preclinical characterization of (89)Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa

      Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 3075-3088

       

   4. Q. Cao, Q. Huang, Y. A. Wang, C. Li. Abraxane-induced bone marrow CD11b(+) myeloid cell depletion in tumor-bearing mice is visualized by μPET-CT with ⁶⁴Cu-labeled anti-CD11b and prevented by anti-CSF-1

      Theranostics, vol. 11, 2021, pp. 3527-3539

       

   5. A. Cavaliere, S. Sun, S. Lee, J. Bodner, Z. Li, Y. Huang, S. L. Moores, B. Marquez-Nostra. Development of ⁸⁹ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer

      Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 383-394

       

   6. M. Chomet, M. Schreurs, M. J. Bolijn, M. Verlaan, W. Beaino, K. Brown, A. J. Poot, A. D. Windhorst, H. Gill, J. Marik, S. Williams, J. Cowell, G. Gasser, T. L. Mindt, Gams van Dongen, D. J. Vugts. Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical ⁸⁹Zr-immuno-PET

      Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 694-707

       

   7. N. Dammes, M. Goldsmith, S. Ramishetti, J. L. J. Dearling, N. Veiga, A. B. Packard, D. Peer. Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics

      Nat Nanotechnol, vol. 16, 2021, pp. 1030-1038

       

   8. P. Diebolder, C. Mpoy, J. Scott, T. T. Huynh, R. Fields, D. Spitzer, N. Bandara, B. E. Rogers. Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44

      J Nucl Med, vol. 62, 2021, pp. 137-143

       

   9. T. V. F. Esposito, H. Stütz, C. Rodríguez-Rodríguez, M. Bergamo, L. Charles, R. Geczy, C. Blackadar, J. P. Kutter, K. Saatchi, U. O. Häfeli. Preparation of Heat-Denatured Macroaggregated Albumin for Biomedical Applications Using a Microfluidics Platform

      ACS Biomater Sci Eng, vol. 7, 2021, pp. 2823-2834

       

   10. S. Fa, K. Adachi, Y. Nagata, K. Egami, K. Kato, T. Ogoshi. Pre-regulation of the planar chirality of pillar[5]arenes for preparing discrete chiral nanotubes

       Chem Sci, vol. 12, 2021, pp. 3483-3488

        

   11. C. A. Ferreira, L. Kang, C. Li, A. Kamkaew, K. E. Barrett, E. Aluicio-Sarduy, Y. Yang, J. W. Engle, D. Jiang, W. Cai. ImmunoPET of the differential expression of CD146 in breast cancer

       Am J Cancer Res, vol. 11, 2021, pp. 1586-1599

        

   12. Y. Funase, E. Nakamura, M. Kajita, Y. Saito, S. Oshikiri, M. Kitano, M. Tokura, A. Hino, T. Uehara. Preclinical Characterization of the Radioimmunoconjugate ¹¹¹In or ⁹⁰Y-FF-21101 Against a P-Cadherin-Expressing Tumor in a Mouse Xenograft Model and a Nonhuman Primate

       J Nucl Med, vol. 62, 2021, pp. 232-239

        

   13. A. Ghai, A. Zheleznyak, M. Mixdorf, J. O\’Neal, J. Ritchey, M. Rettig, J. DiPersio, M. Shokeen, S. Achilefu. Development of [⁸⁹Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma

       Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 1302-1311

        

   14. A. Gonzalez-Junca, O. Reiners, L. D. Borrero-Garcia, D. Beckford-Vera, A. A. Lazar, W. Chou, S. Braunstein, H. VanBrocklin, B. L. Franc, M. H. Barcellos-Hoff. Positron Emission Tomography Imaging of Functional Transforming Growth Factor β (TGFβ) Activity and Benefit of TGFβ Inhibition in Irradiated Intracranial Tumors

       Int J Radiat Oncol Biol Phys, vol. 109, 2021, pp. 527-539

        

   15. L. Hao, N. Rohani, R. T. Zhao, E. M. Pulver, H. Mak, O. J. Kelada, H. Ko, H. E. Fleming, F. B. Gertler, S. N. Bhatia. Microenvironment-triggered multimodal precision diagnostics

       Nat Mater, vol. 20, 2021, pp. 1440-1448

        

   16. K. E. Henry, K. N. Mack, V. L. Nagle, M. Cornejo, A. O. Michel, I. L. Fox, M. Davydova, T. R. Dilling, N. Pillarsetty, J. S. Lewis. ERK Inhibition Improves Anti-PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma

       Mol Cancer Ther, vol. 20, 2021, pp. 2026-2034

        

   17. K. E. Henry, T. M. Shaffer, K. N. Mack, J. Ring, A. Ogirala, S. Klein-Scory, C. Eilert-Micus, W. Schmiegel, T. Bracht, B. Sitek, M. Clyne, C. J. Reid, B. Sipos, J. S. Lewis, H. Kalthoff, J. Grimm. Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer

       J Nucl Med, vol. 62, 2021, pp. 1384-1390

        

   18. Y. Huang, Z. Yang, F. Li, H. Zhao, C. Li, N. Yu, D. J. Hamilton, Z. Li. ⁶⁴Cu/¹⁷⁷Lu-DOTA-diZD, a Small-Molecule-Based Theranostic Pair for Triple-Negative Breast Cancer

       J Med Chem, vol. 64, 2021, pp. 2705-2713

        

   19. C. Hutton, F. Heider, A. Blanco-Gomez, A. Banyard, A. Kononov, X. Zhang, S. Karim, V. Paulus-Hock, D. Watt, N. Steele, S. Kemp, E. K. J. Hogg, J. Kelly, R. F. Jackstadt, F. Lopes, M. Menotti, L. Chisholm, A. Lamarca, J. Valle, O. J. Sansom, C. Springer. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity

       Cancer Cell, vol. 39, 2021, pp. 1227-1244.e20

        

   20. L. Kang, C. Li, Z. T. Rosenkrans, J. W. Engle, R. Wang, D. Jiang, X. Xu, W. Cai. Noninvasive Evaluation of CD20 Expression Using ⁶⁴Cu-Labeled F(ab\’)(2) Fragments of Obinutuzumab in Lymphoma

       J Nucl Med, vol. 62, 2021, pp. 372-378

        

   21. A. Koudrina, E. M. McConnell, J. A. Zurakowski, G. O. Cron, S. Chen, E. C. Tsai, M. C. DeRosa. Exploring the Unique Contrast Properties of Aptamer-Gadolinium Conjugates in Magnetic Resonance Imaging for Targeted Imaging of Thrombi

       ACS Appl Mater Interfaces, vol. 13, 2021, pp. 9412-9424

        

   22. M. Krekorian, G. G. W. Sandker, K. R. G. Cortenbach, O. Tagit, N. K. van Riessen, R. Raavé, M. Srinivas, C. G. Figdor, S. Heskamp, Ehjg Aarntzen. Characterization of Intrinsically Radiolabeled Poly(lactic-co-glycolic acid) Nanoparticles for ex Vivo Autologous Cell Labeling and in Vivo Tracking

       Bioconjug Chem, vol. 32, 2021, pp. 1802-1811

        

   23. S. G. Lee, T. M. Kalidindi, H. Lou, K. Gangangari, B. Punzalan, A. Bitton, C. J. Lee, H. A. Vargas, S. Park, L. Bodei, M. G. Kharas, V. K. Singh, N. V. Kishore Pillarsetty, S. M. Larson. γ-Tocotrienol-Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic Drugs

       J Nucl Med, vol. 62, 2021, pp. 584-590

        

   24. M. Li, W. Wei, T. E. Barnhart, D. Jiang, T. Cao, K. Fan, J. W. Engle, J. Liu, W. Chen, W. Cai. ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma

       Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 2737-2748

        

   25. A. A. Lo, J. Johnston, J. Li, D. Mandikian, M. Hristopoulos, R. Clark, D. Nickles, W. C. Liang, K. Hötzel, D. Dunlap, T. Pham, H. Cai, M. Ovacik, D. Bravo-Perez, E. Mai, D. Slaga, D. Ellerman, J. Ziai, K. Totpal, G. Lee, C. A. Boswell. Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer

       Mol Cancer Ther, vol. 20, 2021, pp. 716-725

        

   26. W. Lu, Y. Cong, D. Yang, D. Chen, G. Yang, Y. Wang, M. E. Van Dort, B. D. Ross, A. P. Mazar, B. B. Chu, H. Hong. Engineered Antibody Fragment against the Urokinase Plasminogen Activator for Fast Delineation of Triple-Negative Breast Cancer by Positron Emission Tomography

       Mol Pharm, vol. 18, 2021, pp. 1690-1698

        

   27. T. Ma, H. Ryu, M. McGregor, B. Babcock, J. Neidleman, G. Xie, A. F. George, J. Frouard, V. Murray, G. Gill, E. Ghosn, E. W. Newell, S. A. Lee, N. R. Roan. Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8(+) T Cells during Convalescence

       J Immunol, vol. 207, 2021, pp. 1344-1356

        

   28. K. E. Martin, A. G. Cosby, E. Boros. Multiplex and In Vivo Optical Imaging of Discrete Luminescent Lanthanide Complexes Enabled by In Situ Cherenkov Radiation Mediated Energy Transfer

       J Am Chem Soc, vol. 143, 2021, pp. 9206-9214

        

   29. M. Minnix, V. Adhikarla, E. Caserta, E. Poku, R. Rockne, J. E. Shively, F. Pichiorri. Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model

       J Nucl Med, vol. 62, 2021, pp. 795-801

        

   30. M. Minnix, L. Li, P. J. Yazaki, A. D. Miller, J. Chea, E. Poku, A. Liu, J. Y. C. Wong, R. C. Rockne, D. Colcher, J. E. Shively. TAG-72-Targeted α-Radionuclide Therapy of Ovarian Cancer Using ²²⁵Ac-Labeled DOTAylated-huCC49 Antibody

       J Nucl Med, vol. 62, 2021, pp. 55-61

        

   31. V. L. Nagle, K. E. Henry, C. A. J. Hertz, M. S. Graham, C. Campos, L. F. Parada, N. Pandit-Taskar, A. Schietinger, I. K. Mellinghoff, J. S. Lewis. Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with ⁶⁴Cu-NOTA-anti-CD8 PET

       Clin Cancer Res, vol. 27, 2021, pp. 1958-1966

        

   32. A. Nomani, G. Li, S. Yousefi, S. Wu, O. M. Malekshah, S. K. Nikkhoi, M. Pourfathi, R. Rizi, A. Hatefi. Gadolinium-labeled affibody-XTEN recombinant vector for detection of HER2+ lesions of ovarian cancer lung metastasis using quantitative MRI

       J Control Release, vol. 337, 2021, pp. 132-143

        

   33. K. Ogawa, H. Echigo, K. Mishiro, S. Hirata, K. Washiyama, Y. Kitamura, K. Takahashi, K. Shiba, S. Kinuya. ⁶⁸Ga- and ²¹¹At-Labeled RGD Peptides for Radiotheranostics with Multiradionuclides

       Mol Pharm, vol. 18, 2021, pp. 3553-3562

        

   34. P. M. R. Pereira, J. Norfleet, J. S. Lewis, F. E. Escorcia. Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition

       J Nucl Med, vol. 62, 2021, pp. 366-371

        

   35. S. Prabhu, H. Deng, T. L. Cross, S. H. Shahoei, C. J. Konopka, N. Gonzalez Medina, C. C. Applegate, M. A. Wallig, L. W. Dobrucki, E. R. Nelson, A. M. Smith, K. S. Swanson. Nanocarriers targeting adipose macrophages increase glucocorticoid anti-inflammatory potency to ameliorate metabolic dysfunction

       Biomater Sci, vol. 9, 2021, pp. 506-518

        

   36. S. Qin, Y. Yu, H. Guan, Y. Yang, F. Sun, Y. Sun, J. Zhu, L. Xing, J. Yu, X. Sun. A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with ⁶⁸Ga-labeled PD-L1 targeted nanobody

       Aging (Albany NY), vol. 13, 2021, pp. 13006-13022

        

   37. S. M. Rathmann, A. R. Genady, N. Janzen, V. Anipindi, S. Czorny, A. F. Rullo, S. Sadeghi, J. F. Valliant. A Versatile Platform for the Development of Radiolabeled Antibody-Recruiting Small Molecules

       Mol Pharm, vol. 18, 2021, pp. 2647-2656

        

   38. J. Ren, M. Xu, J. Chen, J. Ding, P. Wang, L. Huo, F. Li, Z. Liu. PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a ¹⁷⁷Lu-labeled αPD-L1 antibody

       Theranostics, vol. 11, 2021, pp. 304-315

        

   39. M. R. Rudnick, I. M. Wahba, A. K. Leonberg-Yoo, D. Miskulin, H. I. Litt. Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review

       Am J Kidney Dis, vol. 77, 2021, pp. 517-528

        

   40. B. H. Santich, S. M. Cheal, M. Ahmed, M. R. McDevitt, O. Ouerfelli, G. Yang, D. R. Veach, E. K. Fung, M. Patel, D. Burnes Vargas, A. A. Malik, H. F. Guo, P. B. Zanzonico, S. Monette, A. O. Michel, C. M. Rudin, S. M. Larson, N. K. Cheung. A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy

       Clin Cancer Res, vol. 27, 2021, pp. 532-541

        

   41. S. M. Sarrett, O. Keinänen, E. J. Dayts, G. Dewaele-Le Roi, C. Rodriguez, K. E. Carnazza, B. M. Zeglis. Inverse electron demand Diels-Alder click chemistry for pretargeted PET imaging and radioimmunotherapy

       Nat Protoc, vol. 16, 2021, pp. 3348-3381

        

   42. I. Schulien, J. Kemming, V. Oberhardt, K. Wild, L. M. Seidel, S. Killmer, Sagar, F. Daul, M. Salvat Lago, A. Decker, H. Luxenburger, B. Binder, D. Bettinger, O. Sogukpinar, S. Rieg, M. Panning, D. Huzly, M. Schwemmle, G. Kochs, C. F. Waller, A. Nieters, D. Duerschmied, F. Emmerich, H. E. Mei, A. R. Schulz, S. Llewellyn-Lacey, D. A. Price, T. Boettler, B. Bengsch, R. Thimme, M. Hofmann, C. Neumann-Haefelin. Characterization of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells

       Nat Med, vol. 27, 2021, pp. 78-85

        

   43. M. Schwabenland, H. Salié, J. Tanevski, S. Killmer, M. S. Lago, A. E. Schlaak, L. Mayer, J. Matschke, K. Püschel, A. Fitzek, B. Ondruschka, H. E. Mei, T. Boettler, C. Neumann-Haefelin, M. Hofmann, A. Breithaupt, N. Genc, C. Stadelmann, J. Saez-Rodriguez, P. Bronsert, K. P. Knobeloch. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions

       Immunity, vol. 54, 2021, pp. 1594-1610.e11

        

   44. T. Shaffer, A. Natarajan, S. S. Gambhir. PET Imaging of TIGIT Expression on Tumor-Infiltrating Lymphocytes

       Clin Cancer Res, vol. 27, 2021, pp. 1932-1940

        

   45. F. Simonetta, I. S. Alam, J. K. Lohmeyer, B. Sahaf, Z. Good, W. Chen, Z. Xiao, T. Hirai, L. Scheller, P. Engels, O. Vermesh, E. Robinson, T. Haywood, A. Sathirachinda, J. Baker, M. B. Malipatlolla, L. M. Schultz, J. Y. Spiegel, J. T. Lee, D. B. Miklos, C. L. Mackall, S. S. Gambhir, R. S. Negrin. Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET

       Clin Cancer Res, vol. 27, 2021, pp. 1058-1068

        

   46. S. L. Slania, D. Das, A. Lisok, Y. Du, Z. Jiang, R. C. Mease, S. P. Rowe, S. Nimmagadda, X. Yang, M. G. Pomper. Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules

       J Med Chem, vol. 64, 2021, pp. 4059-4070

        

   47. D. Sonanini, C. M. Griessinger, B. F. Schörg, P. Knopf, K. Dittmann, M. Röcken, B. J. Pichler, M. Kneilling. Low-dose total body irradiation facilitates antitumoral Th1 immune responses

       Theranostics, vol. 11, 2021, pp. 7700-7714

        

   48. M. Tognetti, A. Gabor, M. Yang, V. Cappelletti, J. Windhager, O. M. Rueda, K. Charmpi, E. Esmaeilishirazifard, A. Bruna, N. de Souza, C. Caldas, A. Beyer, P. Picotti, J. Saez-Rodriguez, B. Bodenmiller. Deciphering the signaling network of breast cancer improves drug sensitivity prediction

       Cell Syst, vol. 12, 2021, pp. 401-418.e12

        

   49. C. Wang, Y. Chen, Y. N. Hou, Q. Liu, D. Zhang, H. Zhao, Y. Zhang, S. An, L. Li, J. Hou, G. Huang, J. Liu, Y. J. Zhao, W. Wei. ImmunoPET imaging of multiple myeloma with ⁶⁸Ga-NOTA-Nb1053

       Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 2749-2760

        

   50. C. Wang, D. Cheng, N. Jalali Motlagh, E. G. Kuellenberg, G. R. Wojtkiewicz, S. P. Schmidt, R. Stocker, J. W. Chen. Highly Efficient Activatable MRI Probe to Sense Myeloperoxidase Activity

       J Med Chem, vol. 64, 2021, pp. 5874-5885

        

   51. S. Wang, J. Li, J. Hua, Y. Su, D. R. Beckford-Vera, W. Zhao, M. Jayaraman, T. L. Huynh, N. Zhao, Y. H. Wang, Y. Huang, F. Qin, S. Shen, D. Gioeli, R. Dreicer, R. Sriram, E. A. Egusa, J. Chou, F. Y. Feng, R. Aggarwal, M. J. Evans, Y. Seo, B. Liu, R. R. Flavell, J. He. Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET

       Clin Cancer Res, vol. 27, 2021, pp. 1305-1315

        

   52. Y. Wang, H. Ni, S. Zhou, K. He, Y. Gao, W. Wu, M. Wu, Z. Wu, X. Qiu, Y. Zhou, B. Chen, D. Pan, C. Huang, M. Li, Y. Bian, M. Yang, L. Miao, J. Liu. Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity

       Cancer Immunol Immunother, vol. 70, 2021, pp. 365-376

        

   53. N. R. Wong, J. Mohan, B. J. Kopecky, S. Guo, L. Du, J. Leid, G. Feng, I. Lokshina, O. Dmytrenko, H. Luehmann, G. Bajpai, L. Ewald, L. Bell, N. Patel, A. Bredemeyer, C. J. Weinheimer, J. M. Nigro, A. Kovacs, S. Morimoto, P. O. Bayguinov, M. R. Fisher, W. T. Stump, M. Greenberg, J. A. J. Fitzpatrick, S. Epelman, D. Kreisel, R. Sah, Y. Liu, H. Hu, K. J. Lavine. Resident cardiac macrophages mediate adaptive myocardial remodeling

       Immunity, vol. 54, 2021, pp. 2072-2088.e7

        

   54. J. Yang, C. Zhao, J. Lim, L. Zhao, R. L. Tourneau, Q. Zhang, D. Dobson, S. Joshi, J. Pang, X. Zhang, S. Pal, C. Andreou, H. Zhang, M. F. Kircher, H. Schmitthenner. Structurally symmetric near-infrared fluorophore IRDye78-protein complex enables multimodal cancer imaging

       Theranostics, vol. 11, 2021, pp. 2534-2549

        

   55. M. Zhang, J. Ye, Z. Xie, Y. Yan, J. Wang, X. Chen. Optimization of Enzymolysis Clearance Strategy To Enhance Renal Clearance of Radioligands

       Bioconjug Chem, vol. 32, 2021, pp. 2108-2116

        

   56. Y. Zhang, X. Han, G. Nie. Responsive and activable nanomedicines for remodeling the tumor microenvironment

       Nat Protoc, vol. 16, 2021, pp. 405-430

        

2020

1. 1. A. K. Abu-Alfa. Use of Gadolinium-Based Contrast Agents in Kidney Disease Patients: Time for Change

      Am J Kidney Dis, vol. 76, 2020, pp. 436-439

       

   2. M. Agnoletti, C. Rodríguez-Rodríguez, S. N. Kłodzińska, T. V. F. Esposito, K. Saatchi, H. Mørck Nielsen, U. O. Häfeli. Monosized Polymeric Microspheres Designed for Passive Lung Targeting: Biodistribution and Pharmacokinetics after Intravenous Administration

      ACS Nano, vol. 14, 2020, pp. 6693-6706

       

   3. I. S. Alam, F. Simonetta, L. Scheller, A. T. Mayer, S. Murty, O. Vermesh, T. W. Nobashi, J. K. Lohmeyer, T. Hirai, J. Baker, K. H. Lau, R. Negrin, S. S. Gambhir. Visualization of Activated T Cells by OX40-ImmunoPET as a Strategy for Diagnosis of Acute Graft-versus-Host Disease

      Cancer Res, vol. 80, 2020, pp. 4780-4790

       

   4. R. Balhorn, M. C. Balhorn. Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin’s lymphoma to many other types of solid cancers

      Oncotarget, vol. 11, 2020, pp. 3315-3349

       

   5. D. R. Beckford Vera, S. D. Fontaine, H. F. VanBrocklin, B. R. Hearn, R. Reid, G. W. Ashley, D. V. Santi, B. Bengsch, T. Ohtani, O. Khan, M. Setty, S. Manne, S. O’Brien, P. F. Gherardini, R. S. Herati, A. C. Huang, K. M. Chang, E. W. Newell, N. Bovenschen, D. Pe’er, S. M. Albelda, E. J. Wherry. PET Imaging of the EPR Effect in Tumor Xenografts Using Small 15 nm Diameter Polyethylene Glycols Labeled with Zirconium-89

      Mol Cancer Ther, vol. 19, 2020, pp. 673-679

       

   6. E. Berg, H. Gill, J. Marik, A. Ogasawara, S. Williams, G. van Dongen, D. Vugts, S. R. Cherry, A. F. Tarantal. Total-Body PET and Highly Stable Chelators Together Enable Meaningful ⁸⁹Zr-Antibody PET Studies up to 30 Days After Injection

      J Nucl Med, vol. 61, 2020, pp. 453-460

       

   7. C. C. Chen, D. Y. Chang, J. J. Li, H. W. Chan, J. T. Chen, C. H. Chang, R. S. Liu, C. A. Chang, C. L. Chen, H. E. Wang. Investigation of biodistribution and tissue penetration of PEGylated gold nanostars and their application for photothermal cancer treatment in tumor-bearing mice

      J Mater Chem B, vol. 8, 2020, pp. 65-77

       

   8. Z. Chen, M. Chen, Y. Cheng, T. Kowada, J. Xie, X. Zheng, J. Rao. Exploring the Condensation Reaction between Aromatic Nitriles and Amino Thiols To Optimize In Situ Nanoparticle Formation for the Imaging of Proteases and Glycosidases in Cells

      Angew Chem Int Ed Engl, vol. 59, 2020, pp. 3272-3279

       

   9. M. Chomet, M. Schreurs, M. Nguyen, B. Howng, R. Villanueva, M. Krimm, O. Vasiljeva, Gams van Dongen, D. J. Vugts. The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by ⁸⁹Zr-immuno-PET in xenograft bearing mice

      Theranostics, vol. 10, 2020, pp. 5815-5828

       

   10. C. Christensen, L. K. Kristensen, M. Z. Alfsen, C. H. Nielsen, A. Kjaer. Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody

       Eur J Nucl Med Mol Imaging, vol. 47, 2020, pp. 1302-1313

        

   11. A. Corroyer-Dulmont, S. Valable, N. Falzone, A. M. Frelin-Labalme, O. Tietz, J. Toutain, M. S. Soto, D. Divoux, L. Chazalviel, E. A. Pérès, N. R. Sibson, K. A. Vallis, M. Bernaudin. VCAM-1 targeted alpha-particle therapy for early brain metastases

       Neuro Oncol, vol. 22, 2020, pp. 357-368

        

   12. W. Dawicki, K. J. H. Allen, R. Garg, E. M. Geoghegan, M. S. Berger, D. L. Ludwig, E. Dadachova. Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy

       Oncotarget, vol. 11, 2020, pp. 3571-3581

        

   13. J. M. de Gooyer, F. M. K. Elekonawo, D. L. Bos, R. S. van der Post, A. Pèlegrin, B. Framery, F. Cailler, A. L. Vahrmeijer, J. H. W. de Wilt, M. Rijpkema. Multimodal CEA-Targeted Image-Guided Colorectal Cancer Surgery using ¹¹¹In-Labeled SGM-101

       Clin Cancer Res, vol. 26, 2020, pp. 5934-5942

        

   14. D. N. Dorst, M. Rijpkema, M. Boss, B. Walgreen, M. M. A. Helsen, D. L. Bos, M. Brom, C. Klein, P. Laverman, P. M. van der Kraan, M. Gotthardt, M. I. Koenders, M. Buitinga. Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis

       Rheumatology (Oxford), vol. 59, 2020, pp. 3952-3960

        

   15. L. Droctové, M. Lancien, V. L. Tran, M. Susset, B. Jego, F. Theodoro, P. Kessler, G. Mourier, P. Robin, S. S. Diarra, S. Palea, A. Flahault, A. Chorfa, M. Corbani, C. Llorens-Cortes, B. Mouillac, C. Mendre, A. Pruvost, D. Servent, C. Truillet, N. Gilles. A snake toxin as a theranostic agent for the type 2 vasopressin receptor

       Theranostics, vol. 10, 2020, pp. 11580-11594

        

   16. F. E. Escorcia, J. L. Houghton, D. Abdel-Atti, P. R. Pereira, A. Cho, N. T. Gutsche, K. E. Baidoo, J. S. Lewis. ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors

       Theranostics, vol. 10, 2020, pp. 151-165

        

   17. X. Feng, Y. Wang, D. Lu, X. Xu, X. Zhou, H. Zhang, T. Zhang, H. Zhu, Z. Yang, F. Wang, N. Li, Z. Liu. Clinical Translation of a ⁶⁸Ga-Labeled Integrin α v β 6-Targeting Cyclic Radiotracer for PET Imaging of Pancreatic Cancer

       J Nucl Med, vol. 61, 2020, pp. 1461-1467

        

   18. T. M. Fenton, P. B. Jørgensen, K. Niss, S. J. S. Rubin, U. M. Mörbe, L. B. Riis, C. Da Silva, A. Plumb, J. Vandamme, H. L. Jakobsen, S. Brunak, A. Habtezion, O. H. Nielsen, B. Johansson-Lindbom, W. W. Agace. Immune Profiling of Human Gut-Associated Lymphoid Tissue Identifies a Role for Isolated Lymphoid Follicles in Priming of Region-Specific Immunity

       Immunity, vol. 52, 2020, pp. 557-570.e6

        

   19. Gfds Fernandes, H. R. N. Salgado, J. L. D. Santos. A critical review of HPLC-based analytical methods for quantification of Linezolid

       Crit Rev Anal Chem, vol. 50, 2020, pp. 196-211

        

   20. E. Friebel, K. Kapolou, S. Unger, N. G. Núñez, S. Utz, E. J. Rushing, L. Regli, M. Weller, M. Greter, S. Tugues, M. C. Neidert, B. Becher. Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes

       Cell, vol. 181, 2020, pp. 1626-1642.e20

        

   21. Jacm Goos, A. Cho, L. M. Carter, T. R. Dilling, M. Davydova, K. Mandleywala, S. Puttick, A. Gupta, W. S. Price, J. F. Quinn, M. R. Whittaker, J. S. Lewis, T. P. Davis. Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect

       Theranostics, vol. 10, 2020, pp. 567-584

        

   22. J. R. Henriksen, T. B. Engel, A. L. Petersen, P. J. Kempen, F. Melander, P. Roos, R. I. Jølck, T. L. Andresen. Elucidating the anomalous membrane permeability of Ag(I), Cu(II), Zn(II) and Au(III) towards new nanoreactor strategies for synthesizing metal nanoparticles

       Nanoscale, vol. 12, 2020, pp. 22298-22306

        

   23. S. Hossaini Nasr, Z. Rashidijahanabad, S. Ramadan, N. Kauffman, N. Parameswaran, K. R. Zinn, C. Qian, R. Arora, D. Agnew, X. Huang. Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles

       Nanoscale, vol. 12, 2020, pp. 9541-9556

        

   24. R. Houštecká, M. Hadzima, J. Fanfrlík, J. Brynda, L. Pallová, I. Hánová, H. Mertlíková-Kaiserová, M. Lepšík, M. Horn, M. Smrčina, P. Majer, M. Mareš. Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis

       J Med Chem, vol. 63, 2020, pp. 1576-1596

        

   25. C. W. Huang, Y. H. Chang, H. H. Lee, J. Y. Wu, J. X. Huang, Y. H. Chung, S. T. Hsu, L. P. Chow, K. C. Wei, F. T. Huang. Irisin, an exercise myokine, potently suppresses tumor proliferation, invasion, and growth in glioma

       Faseb j, vol. 34, 2020, pp. 9678-9693

        

   26. A. Karimian, N. T. Ji, H. Song, G. Sgouros. Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy

       Cancer Res, vol. 80, 2020, pp. 868-876

        

   27. V. J. Kelly, S. T. Wu, V. Gottumukkala, R. Coelho, K. Palmer, S. Nair, T. Erick, R. Puri, O. Ilovich, P. Mukherjee. Preclinical evaluation of an (111)In/(225)Ac theranostic targeting transformed MUC1 for triple negative breast cancer

       Theranostics, vol. 10, 2020, pp. 6946-6958

        

   28. A. Kolstad, T. Illidge, N. Bolstad, S. Spetalen, U. Madsbu, C. Stokke, J. Blakkisrud, A. Løndalen, N. O\’Rourke, M. Beasley, W. Jurczak, U. M. Fagerli, M. Kaščák, M. Bayne, A. Obr, J. Dahle, L. Rojkjaer, V. Pascal, H. Holte. Phase 1/2a study of ¹⁷⁷Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

       Blood Adv, vol. 4, 2020, pp. 4091-4101

        

   29. K. E. Lindsay, D. Vanover, M. Thoresen, H. King, P. Xiao, P. Badial, M. Araínga, S. B. Park, P. M. Tiwari, H. E. Peck, E. L. Blanchard, J. M. Feugang, A. K. Olivier, C. Zurla, F. Villinger, A. R. Woolums, P. J. Santangelo. Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa Leads to Durable Expression of Broadly Neutralizing Antibodies against HIV

       Mol Ther, vol. 28, 2020, pp. 805-819

        

   30. D. Lobeek, M. Rijpkema, S. Y. A. Terry, J. D. M. Molkenboer-Kuenen, L. Joosten, E. A. J. van Genugten, A. C. H. van Engen-van Grunsven, Jham Kaanders, S. A. H. Pegge, O. C. Boerman, W. L. J. Weijs, M. A. W. Merkx, C. M. L. van Herpen, R. P. Takes, Ehjg Aarntzen, W. J. G. Oyen. Imaging angiogenesis in patients with head and neck squamous cell carcinomas by ⁶⁸Ga-DOTA-E-[c(RGDfK)] 2 PET/CT

       Eur J Nucl Med Mol Imaging, vol. 47, 2020, pp. 2647-2655

        

   31. G. Lv, X. Sun, L. Qiu, Y. Sun, K. Li, Q. Liu, Q. Zhao, S. Qin, J. Lin. PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody

       J Nucl Med, vol. 61, 2020, pp. 117-122

        

   32. N. Nair, S. Y. Chen, E. Lemmens, S. Chang, D. T. Le, E. M. Jaffee, A. Murphy, C. Whiting, T. Müller, D. G. Brockstedt. Single-Cell Immune Competency Signatures Associate with Survival in Phase II GVAX and CRS-207 Randomized Studies in Patients with Metastatic Pancreatic Cancer

       Cancer Immunol Res, vol. 8, 2020, pp. 609-617

        

   33. T. D. T. Nguyen, R. Marasini, S. Rayamajhi, C. Aparicio, D. Biller, S. Aryal. Erythrocyte membrane concealed paramagnetic polymeric nanoparticle for contrast-enhanced magnetic resonance imaging

       Nanoscale, vol. 12, 2020, pp. 4137-4149

        

   34. Y. C. Ou, X. Wen, C. A. Johnson, D. Shae, O. D. Ayala, J. A. Webb, E. C. Lin, R. C. DeLapp, K. L. Boyd, A. Richmond, A. Mahadevan-Jansen, M. Rafat, J. T. Wilson, J. M. Balko, M. N. Tantawy, A. E. Vilgelm, R. Bardhan. Multimodal Multiplexed Immunoimaging with Nanostars to Detect Multiple Immunomarkers and Monitor Response to Immunotherapies

       ACS Nano, vol. 14, 2020, pp. 651-663

        

   35. N. Pandit-Taskar, M. A. Postow, M. D. Hellmann, J. J. Harding, C. A. Barker, J. A. O\’Donoghue, M. Ziolkowska, S. Ruan, S. K. Lyashchenko, F. Tsai, M. Farwell, T. C. Mitchell, R. Korn, W. Le, J. S. Lewis, W. A. Weber, D. Behera, I. Wilson, M. Gordon, A. M. Wu, J. D. Wolchok. First-in-Humans Imaging with ⁸⁹Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting

       J Nucl Med, vol. 61, 2020, pp. 512-519

        

   36. E. Peplau, F. De Rose, S. Reder, M. Mittelhäuser, G. Scafetta, M. Schwaiger, W. A. Weber, A. Bartolazzi, A. Skerra, C. D\’Alessandria. Development of a Chimeric Antigen-Binding Fragment Directed Against Human Galectin-3 and Validation as an Immuno-Positron Emission Tomography Tracer for the Sensitive In Vivo Imaging of Thyroid Cancer

       Thyroid, vol. 30, 2020, pp. 1314-1326

        

   37. P. M. R. Pereira, K. Mandleywala, A. Ragupathi, J. S. Lewis. Acute Statin Treatment Improves Antibody Accumulation in EGFR- and PSMA-Expressing Tumors

       Clin Cancer Res, vol. 26, 2020, pp. 6215-6229

        

   38. A. Pichard, S. Marcatili, J. Karam, J. Constanzo, R. Ladjohounlou, A. Courteau, M. Jarlier, N. Bonnefoy, S. Patzke, V. Stenberg, P. Coopman, G. Cartron, I. Navarro-Teulon, A. Repetto-Llamazares, H. Heyerdahl, J. Dahle, M. Bardiès, J. P. Pouget. The therapeutic effectiveness of ¹⁷⁷Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest

       Leukemia, vol. 34, 2020, pp. 1315-1328

        

   39. X. Qin, J. Sufi, P. Vlckova, P. Kyriakidou, S. E. Acton, V. S. W. Li, M. Nitz, C. J. Tape. Cell-type-specific signaling networks in heterocellular organoids

       Nat Methods, vol. 17, 2020, pp. 335-342

        

   40. I. Quelven, J. Monteil, M. Sage, A. Saidi, J. Mounier, A. Bayout, J. Garrier, M. Cogne, S. Durand-Panteix. ²¹²Pb α-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study

       J Nucl Med, vol. 61, 2020, pp. 1058-1065

        

   41. S. Rayamajhi, R. Marasini, T. D. T. Nguyen, B. L. Plattner, D. Biller, S. Aryal. Strategic reconstruction of macrophage-derived extracellular vesicles as a magnetic resonance imaging contrast agent

       Biomater Sci, vol. 8, 2020, pp. 2887-2904

        

   42. E. K. Sarbisheh, A. K. Salih, S. J. Raheem, J. S. Lewis, E. W. Price. A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89

       Inorg Chem, vol. 59, 2020, pp. 11715-11727

        

   43. L. J. Savic, L. A. Doemel, I. T. Schobert, R. R. Montgomery, N. Joshi, J. J. Walsh, J. Santana, V. Pekurovsky, X. Zhang, M. Lin, L. Adam, A. Boustani, J. Duncan, L. Leng, R. J. Bucala, S. N. Goldberg, F. Hyder, D. Coman, J. Chapiro. Molecular MRI of the Immuno-Metabolic Interplay in a Rabbit Liver Tumor Model: A Biomarker for Resistance Mechanisms in Tumor-targeted Therapy?

       Radiology, vol. 296, 2020, pp. 575-583

        

   44. L. J. Savic, I. T. Schobert, D. Peters, J. J. Walsh, F. M. Laage-Gaupp, C. A. Hamm, N. Tritz, L. A. Doemel, M. Lin, A. Sinusas, T. Schlachter, J. S. Duncan, F. Hyder, D. Coman, J. Chapiro. Molecular Imaging of Extracellular Tumor pH to Reveal Effects of Locoregional Therapy on Liver Cancer Microenvironment

       Clin Cancer Res, vol. 26, 2020, pp. 428-438

        

   45. M. L. Senders, A. E. Meerwaldt, M. M. T. van Leent, B. L. Sanchez-Gaytan, J. C. van de Voort, Y. C. Toner, A. Maier, E. D. Klein, N. A. T. Sullivan, A. M. Sofias, H. Groenen, C. Faries, R. S. Oosterwijk, E. M. van Leeuwen, F. Fay, E. Chepurko, T. Reiner, R. Duivenvoorden, L. Zangi, R. M. Dijkhuizen, S. Hak. Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging

       Nat Nanotechnol, vol. 15, 2020, pp. 398-405

        

   46. B. Shi, B. Zhang, Y. Zhang, Y. Gu, C. Zheng, J. Yan, W. Chen, F. Yan, J. Ye, H. Zhang. Multifunctional gap-enhanced Raman tags for preoperative and intraoperative cancer imaging

       Acta Biomater, vol. 104, 2020, pp. 210-220

        

   47. S. Slight-Webb, M. Smith, A. Bylinska, S. Macwana, C. Guthridge, R. Lu, J. T. Merrill, E. Chakravarty, C. Arriens, M. E. Munroe, H. T. Maecker, P. J. Utz, J. M. Guthridge, J. A. James. Autoantibody-positive healthy individuals with lower lupus risk display a unique immune endotype

       J Allergy Clin Immunol, vol. 146, 2020, pp. 1419-1433

        

   48. R. Tang, A. Zheleznyak, M. Mixdorf, A. Ghai, J. Prior, K. C. L. Black, M. Shokeen, N. Reed, P. Biswas, S. Achilefu. Osteotropic Radiolabeled Nanophotosensitizer for Imaging and Treating Multiple Myeloma

       ACS Nano, vol. 14, 2020, pp. 4255-4264

        

   49. L. Tortola, A. Jacobs, L. Pohlmeier, F. J. Obermair, F. Ampenberger, B. Bodenmiller, M. Kopf. High-Dimensional T Helper Cell Profiling Reveals a Broad Diversity of Stably Committed Effector States and Uncovers Interlineage Relationships

       Immunity, vol. 53, 2020, pp. 597-613.e6

        

   50. G. A. Ulaner, N. B. Sobol, J. A. O’Donoghue, A. S. Kirov, C. C. Riedl, R. Min, E. Smith, L. M. Carter, S. K. Lyashchenko, J. S. Lewis, C. O. Landgren. CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging

       Radiology, vol. 295, 2020, pp. 606-615

        

   51. T. J. van Oostenbrugge, J. F. Langenhuijsen, E. Oosterwijk, O. C. Boerman, S. F. Jenniskens, W. J. G. Oyen, J. J. Fütterer, P. F. A. Mulders. Follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with ¹¹¹In-girentuximab

       Eur J Nucl Med Mol Imaging, vol. 47, 2020, pp. 1864-1870

        

   52. B. A. Vaughn, A. M. Brown, S. H. Ahn, J. R. Robinson, E. Boros. Is Less More? Influence of the Coordination Geometry of Copper(II) Picolinate Chelate Complexes on Metabolic Stability

       Inorg Chem, vol. 59, 2020, pp. 16095-16108

        

   53. Y. Wang, C. Zhang, J. Lai, Y. Zhao, D. Lu, R. Bao, X. Feng, T. Zhang, Z. Liu. Noninvasive PET tracking of post-transplant gut microbiota in living mice

       Eur J Nucl Med Mol Imaging, vol. 47, 2020, pp. 991-1002

        

   54. W. Wei, D. Jiang, H. J. Lee, M. Li, C. J. Kutyreff, J. W. Engle, J. Liu, W. Cai. Development and characterization of CD54-targeted immunoPET imaging in solid tumors

       Eur J Nucl Med Mol Imaging, vol. 47, 2020, pp. 2765-2775

        

   55. A. W. Woodham, S. H. Zeigler, E. L. Zeyang, S. C. Kolifrath, R. W. Cheloha, M. Rashidian, R. J. Chaparro, R. D. Seidel, S. J. Garforth, J. L. Dearling, M. Mesyngier, P. K. Duddempudi, A. B. Packard, S. C. Almo, H. L. Ploegh. In vivo detection of antigen-specific CD8(+) T cells by immuno-positron emission tomography

       Nat Methods, vol. 17, 2020, pp. 1025-1032

        

   56. Z. Xiao, A. T. Mayer, T. W. Nobashi, S. S. Gambhir. ICOS Is an Indicator of T-cell-Mediated Response to Cancer Immunotherapy

       Cancer Res, vol. 80, 2020, pp. 3023-3032

        

   57. C. Xu, H. Hong, Y. Lee, K. S. Park, M. Sun, T. Wang, M. E. Aikins, Y. Xu, J. J. Moon. Efficient Lymph Node-Targeted Delivery of Personalized Cancer Vaccines with Reactive Oxygen Species-Inducing Reduced Graphene Oxide Nanosheets

       ACS Nano, vol. 14, 2020, pp. 13268-13278

        

   58. A. C. Yang, M. Y. Stevens, M. B. Chen, D. P. Lee, D. Stähli, D. Gate, K. Contrepois, W. Chen, T. Iram, L. Zhang, R. T. Vest, A. Chaney, B. Lehallier, N. Olsson, H. du Bois, R. Hsieh, H. C. Cropper, D. Berdnik, L. Li, E. Y. Wang, G. M. Traber. Physiological blood-brain transport is impaired with age by a shift in transcytosis

       Nature, vol. 583, 2020, pp. 425-430

        

   59. H. Zhu, T. L. Liu, C. H. Liu, J. Wang, H. Zhang, B. Dong, J. Shen, C. K. Zhao, Z. F. Li, Z. Cheng, Z. Yang. Evaluation of a novel monoclonal antibody mAb109 by immuno-PET/fluorescent imaging for noninvasive lung adenocarcinoma diagnosis

       Acta Pharmacol Sin, vol. 41, 2020, pp. 101-109

        

2019

1. 1. S. R. Banerjee, V. Kumar, A. Lisok, D. Plyku, Z. Nováková, M. Brummet, B. Wharram, C. Barinka, R. Hobbs, M. G. Pomper. Evaluation of ¹¹¹In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen

      J Nucl Med, vol. 60, 2019, pp. 400-406

       

   2. N. Beziere, K. Fuchs, A. Maurer, G. Reischl, J. Brück, K. Ghoreschi, B. Fehrenbacher, D. C. Berrio, K. Schenke-Layland, U. Kohlhofer, L. Quintanilla-Martinez, M. Gawaz, M. Kneilling, B. Pichler. Imaging fibrosis in inflammatory diseases: targeting the exposed extracellular matrix

      Theranostics, vol. 9, 2019, pp. 2868-2881

       

   3. D. V. Bower, J. K. Richter, H. von Tengg-Kobligk, J. T. Heverhagen, V. M. Runge. Gadolinium-Based MRI Contrast Agents Induce Mitochondrial Toxicity and Cell Death in Human Neurons, and Toxicity Increases With Reduced Kinetic Stability of the Agent

      Invest Radiol, vol. 54, 2019, pp. 453-463

       

   4. J. Boyken, T. Frenzel, J. Lohrke, G. Jost, G. Schütz, H. Pietsch. Impact of Treatment With Chelating Agents Depends on the Stability of Administered GBCAs: A Comparative Study in Rats

      Invest Radiol, vol. 54, 2019, pp. 76-82

       

   5. C. Buchwalder, M. G. Jaraquemada-Peláez, J. Rousseau, H. Merkens, C. Rodríguez-Rodríguez, C. Orvig, F. Bénard, P. Schaffer, K. Saatchi, U. O. Häfeli. Evaluation of the Tetrakis(3-Hydroxy-4-Pyridinone) Ligand THPN with Zirconium(IV): Thermodynamic Solution Studies, Bifunctionalization, and in Vivo Assessment of Macromolecular ⁸⁹Zr-THPN-Conjugates

      Inorg Chem, vol. 58, 2019, pp. 14667-14681

       

   6. L. Budzinski, A. R. Schulz, S. Baumgart, T. Burns, T. Rose, H. Hirseland, H. E. Mei. Osmium-Labeled Microspheres for Bead-Based Assays in Mass Cytometry

      J Immunol, vol. 202, 2019, pp. 3103-3112

       

   7. E. R. Butch, P. E. Mead, V. Amador Diaz, H. Tillman, E. Stewart, J. K. Mishra, J. Kim, A. Bahrami, J. L. J. Dearling, A. B. Packard, S. V. Stoddard, A. L. Vāvere, Y. Han, B. L. Shulkin, S. E. Snyder. Positron Emission Tomography Detects In Vivo Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma

      Cancer Res, vol. 79, 2019, pp. 3112-3124

       

   8. Q. Cao, Q. Huang, C. Mohan, C. Li. Small-Animal PET/CT Imaging of Local and Systemic Immune Response Using ⁶⁴Cu-αCD11b

      J Nucl Med, vol. 60, 2019, pp. 1317-1324

       

   9. D. Chen, Y. Zhou, D. Yang, M. Guan, M. Zhen, W. Lu, M. E. Van Dort, B. D. Ross, C. Wang, C. Shu, H. Hong. Positron Emission Tomography/Magnetic Resonance Imaging of Glioblastoma Using a Functionalized Gadofullerene Nanoparticle

      ACS Appl Mater Interfaces, vol. 11, 2019, pp. 21343-21352

       

   10. N. Dmochowska, W. Tieu, M. D. Keller, H. R. Wardill, C. Mavrangelos, M. A. Campaniello, P. Takhar, P. A. Hughes. Immuno-PET of Innate Immune Markers CD11b and IL-1β Detects Inflammation in Murine Colitis

       J Nucl Med, vol. 60, 2019, pp. 858-863

        

   11. C. A. Dutertre, E. Becht, S. E. Irac, A. Khalilnezhad, V. Narang, S. Khalilnezhad, P. Y. Ng, L. L. van den Hoogen, J. Y. Leong, B. Lee, M. Chevrier, X. M. Zhang, P. J. A. Yong, G. Koh, J. Lum, S. W. Howland, E. Mok, J. Chen, A. Larbi, H. K. K. Tan, T. K. H. Lim, P. Karagianni, A. G. Tzioufas, B. Malleret, J. Brody, S. Albani, J. van Roon, T. Radstake, E. W. Newell, F. Ginhoux. Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells

       Immunity, vol. 51, 2019, pp. 573-589.e8

        

   12. W. Fan, W. Zhang, S. Alshehri, T. R. Neeley, J. C. Garrison. Enhanced tumor retention of NTSR1-targeted agents by employing a hydrophilic cysteine cathepsin inhibitor

       Eur J Med Chem, vol. 177, 2019, pp. 386-400

        

   13. Q. Fu, A. Piai, W. Chen, K. Xia, J. J. Chou. Structure determination protocol for transmembrane domain oligomers

       Nat Protoc, vol. 14, 2019, pp. 2483-2520

        

   14. J. Garousi, S. Lindbo, J. Borin, E. von Witting, A. Vorobyeva, M. Oroujeni, B. Mitran, A. Orlova, J. Buijs, V. Tolmachev, S. Hober. Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours

       Eur J Pharm Biopharm, vol. 134, 2019, pp. 37-48

        

   15. K. E. Henry, M. M. Dacek, T. R. Dilling, J. D. Caen, I. L. Fox, M. J. Evans, J. S. Lewis. A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer

       Clin Cancer Res, vol. 25, 2019, pp. 166-176

        

   16. S. Heskamp, P. J. Wierstra, J. D. M. Molkenboer-Kuenen, G. W. Sandker, S. Thordardottir, J. Cany, D. Olive, J. Bussink, O. C. Boerman, H. Dolstra, Ehjg Aarntzen, W. A. Hobo. PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

       Cancer Immunol Res, vol. 7, 2019, pp. 150-161

        

   17. S. H. L. Hoffmann, D. I. Reck, A. Maurer, B. Fehrenbacher, J. E. Sceneay, M. Poxleitner, H. H. Öz, W. Ehrlichmann, G. Reischl, K. Fuchs, M. Schaller, D. Hartl, M. Kneilling, A. Möller, B. J. Pichler, C. M. Griessinger. Visualization and quantification of in vivo homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer

       Theranostics, vol. 9, 2019, pp. 5869-5885

        

   18. S. Imlimthan, S. Otaru, O. Keinänen, A. Correia, K. Lintinen, H. A. Santos, A. J. Airaksinen, M. A. Kostiainen, M. Sarparanta. Radiolabeled Molecular Imaging Probes for the In Vivo Evaluation of Cellulose Nanocrystals for Biomedical Applications

       Biomacromolecules, vol. 20, 2019, pp. 674-683

        

   19. N. Jailkhani, J. R. Ingram, M. Rashidian, S. Rickelt, C. Tian, H. Mak, Z. Jiang, H. L. Ploegh, R. O. Hynes. Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix

       Proc Natl Acad Sci U S A, vol. 116, 2019, pp. 14181-14190

        

   20. L. K. Kristensen, C. Christensen, M. M. Jensen, B. J. Agnew, C. Schjöth-Frydendahl, A. Kjaer, C. H. Nielsen. Site-specifically labeled ⁸⁹Zr-DFO-trastuzumab improves immuno-reactivity and tumor uptake for immuno-PET in a subcutaneous HER2-positive xenograft mouse model

       Theranostics, vol. 9, 2019, pp. 4409-4420

        

   21. L. K. Kristensen, C. Fröhlich, C. Christensen, M. C. Melander, T. T. Poulsen, G. R. Galler, J. Lantto, I. D. Horak, M. Kragh, C. H. Nielsen, A. Kjaer. CD4(+) and CD8a(+) PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models

       Theranostics, vol. 9, 2019, pp. 8221-8238

        

   22. R. Ladjohounlou, C. Lozza, A. Pichard, J. Constanzo, J. Karam, P. Le Fur, E. Deshayes, V. Boudousq, S. Paillas, M. Busson, M. Le Blay, M. Jarlier, S. Marcatili, M. Bardiès, F. Bruchertseifer, A. Morgenstern, J. Torgue, I. Navarro-Teulon, J. P. Pouget. Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy

       Clin Cancer Res, vol. 25, 2019, pp. 4775-4790

        

   23. H. J. Lee, E. B. Ehlerding, D. Jiang, T. E. Barnhart, T. Cao, W. Wei, C. A. Ferreira, P. Huang, J. W. Engle, W. Cai. Dual-labeled pertuzumab for multimodality image-guided ovarian tumor resection

       Am J Cancer Res, vol. 9, 2019, pp. 1454-1468

        

   24. W. G. Lesniak, C. Chu, A. Jablonska, B. Behnam Azad, O. Zwaenepoel, M. Zawadzki, A. Lisok, M. G. Pomper, P. Walczak, J. Gettemans, M. Janowski. PET imaging of distinct brain uptake of a nanobody and similarly-sized PAMAM dendrimers after intra-arterial administration

       Eur J Nucl Med Mol Imaging, vol. 46, 2019, pp. 1940-1951

        

   25. W. G. Lesniak, C. Chu, A. Jablonska, Y. Du, M. G. Pomper, P. Walczak, M. Janowski. A Distinct Advantage to Intraarterial Delivery of ⁸⁹Zr-Bevacizumab in PET Imaging of Mice With and Without Osmotic Opening of the Blood-Brain Barrier

       J Nucl Med, vol. 60, 2019, pp. 617-622

        

   26. M. Li, D. Jiang, T. E. Barnhart, T. Cao, J. W. Engle, W. Chen, W. Cai. Immuno-PET imaging of VEGFR-2 expression in prostate cancer with ⁸⁹Zr-labeled ramucirumab

       Am J Cancer Res, vol. 9, 2019, pp. 2037-2046

        

   27. Y. Liang, Q. Liu, Y. Zhou, S. Chen, L. Yang, M. Zhu, Q. Wang. Counting and Recognizing Single Bacterial Cells by a Lanthanide-Encoding Inductively Coupled Plasma Mass Spectrometric Approach

       Anal Chem, vol. 91, 2019, pp. 8341-8349

        

   28. A. Y. Liu, A. D. Kanan, T. P. Radon, S. Shah, M. E. Weeks, J. M. Foster, J. K. Sosabowski, L. Dumartin, T. Crnogorac-Jurcevic. AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting

       Oncotarget, vol. 10, 2019, pp. 4276-4289

        

   29. Q. Liu, E. M. Johnson, R. K. Lam, Q. Wang, H. Bo Ye, E. N. Wilson, P. S. Minhas, L. Liu, M. S. Swarovski, S. Tran, J. Wang, S. S. Mehta, X. Yang, J. D. Rabinowitz, S. S. Yang, M. Shamloo, C. Mueller, M. L. James, K. I. Andreasson. Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity

       Nat Immunol, vol. 20, 2019, pp. 1023-1034

        

   30. Y. Liu, H. P. Luehmann, L. Detering, E. D. Pressly, A. J. McGrath, D. Sultan, A. Nguyen, S. Grathwohl, M. Shokeen, M. Zayed, R. J. Gropler, D. Abendschein, C. J. Hawker, P. K. Woodard. Assessment of Targeted Nanoparticle Assemblies for Atherosclerosis Imaging with Positron Emission Tomography and Potential for Clinical Translation

       ACS Appl Mater Interfaces, vol. 11, 2019, pp. 15316-15321

        

   31. C. Lohrmann, E. M. O’Reilly, J. A. O’Donoghue, N. Pandit-Taskar, J. A. Carrasquillo, S. K. Lyashchenko, S. Ruan, R. Teng, W. Scholz, P. W. Maffuid, J. S. Lewis, W. A. Weber. Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer

       Clin Cancer Res, vol. 25, 2019, pp. 7014-7023

        

   32. X. K. Lun, D. Szklarczyk, A. Gabor, N. Dobberstein, V. R. T. Zanotelli, J. Saez-Rodriguez, C. von Mering, B. Bodenmiller. Analysis of the Human Kinome and Phosphatome by Mass Cytometry Reveals Overexpression-Induced Effects on Cancer-Related Signaling

       Mol Cell, vol. 74, 2019, pp. 1086-1102.e5

        

   33. S. Lütje, S. Heskamp, G. M. Franssen, C. Frielink, A. Kip, M. Hekman, G. Fracasso, M. Colombatti, K. Herrmann, O. C. Boerman, M. Gotthardt, M. Rijpkema. Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors

       Theranostics, vol. 9, 2019, pp. 2924-2938

        

   34. A. F. Maaland, H. Heyerdahl, A. O’Shea, B. Eiriksdottir, V. Pascal, J. T. Andersen, A. Kolstad, J. Dahle. Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate (177)Lu-NNV003

       Eur J Nucl Med Mol Imaging, vol. 46, 2019, pp. 2311-2321

        

   35. O. A. Marcos-Contreras, J. S. Brenner, R. Y. Kiseleva, V. Zuluaga-Ramirez, C. F. Greineder, C. H. Villa, E. D. Hood, J. W. Myerson, S. Muro, Y. Persidsky, V. R. Muzykantov. Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain

       J Control Release, vol. 301, 2019, pp. 54-61

        

   36. H. Mukai, K. Hatanaka, N. Yagi, S. Warashina, M. Zouda, M. Takahashi, K. Narushima, H. Yabuuchi, J. Iwano, T. Kuboyama, J. Enokizono, Y. Wada, Y. Watanabe. Pharmacokinetic evaluation of liposomal nanoparticle-encapsulated nucleic acid drug: A combined study of dynamic PET imaging and LC/MS/MS analysis

       J Control Release, vol. 294, 2019, pp. 185-194

        

   37. A. Natarajan, C. B. Patel, S. Ramakrishnan, P. S. Panesar, S. R. Long, S. S. Gambhir. A Novel Engineered Small Protein for Positron Emission Tomography Imaging of Human Programmed Death Ligand-1: Validation in Mouse Models and Human Cancer Tissues

       Clin Cancer Res, vol. 25, 2019, pp. 1774-1785

        

   38. A. C. L. Opina, M. Strickland, Y. S. Lee, N. Tjandra, R. E. Swenson, O. Vasalatiy. Comparison of Solution Properties of Polymethylated DOTA-like Lanthanide Complexes with Opposite Chirality of the Pendant Arms

       Inorg Chem, vol. 58, 2019, pp. 15788-15800

        

   39. L. Pan, T. M. Fu, W. Zhao, L. Zhao, W. Chen, C. Qiu, W. Liu, Z. Liu, A. Piai, Q. Fu, S. Chen, H. Wu, J. J. Chou. Higher-Order Clustering of the Transmembrane Anchor of DR5 Drives Signaling

       Cell, vol. 176, 2019, pp. 1477-1489.e14

        

   40. D. N. Pandya, N. B. Bhatt, F. Almaguel, S. Rideout-Danner, H. D. Gage, K. K. Solingapuram Sai, T. J. Wadas. ⁸⁹Zr-Chloride Can Be Used for Immuno-PET Radiochemistry Without Loss of Antigen Reactivity In Vivo

       J Nucl Med, vol. 60, 2019, pp. 696-701

        

   41. H. H. Pang, P. Y. Chen, K. C. Wei, C. W. Huang, Y. L. Shiue, C. Y. Huang, H. W. Yang. Convection-Enhanced Delivery of a Virus-Like Nanotherapeutic Agent with Dual-Modal Imaging for Besiegement and Eradication of Brain Tumors

       Theranostics, vol. 9, 2019, pp. 1752-1763

        

   42. P. M. R. Pereira, K. Mandleywala, A. Ragupathi, L. M. Carter, Jacm Goos, Y. Y. Janjigian, J. S. Lewis. Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors

       J Nucl Med, vol. 60, 2019, pp. 1569-1578

        

   43. J. Riegler, H. Gill, A. Ogasawara, M. Hedehus, V. Javinal, J. Oeh, G. Z. Ferl, J. Marik, S. Williams, D. Sampath, J. Schartner, R. A. D. Carano. VCAM-1 Density and Tumor Perfusion Predict T-cell Infiltration and Treatment Response in Preclinical Models

       Neoplasia, vol. 21, 2019, pp. 1036-1050

        

   44. D. R. Roberts, A. R. Chatterjee. The Critical Need for Pediatric and Juvenile Animal Research Addressing Gadolinium Retention in the Developing Body

       Invest Radiol, vol. 54, 2019, pp. 72-75

        

   45. E. Sanabria Español, M. Maldonado. Host-Guest Recognition of Pesticides by Calixarenes

       Crit Rev Anal Chem, vol. 49, 2019, pp. 383-394

        

   46. N. Schaduangrat, V. Prachayasittikul, S. Choomwattana, P. Wongchitrat, K. Phopin, W. Suwanjang, A. A. Malik, B. Vincent, C. Nantasenamat. Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer’s disease

       Med Res Rev, vol. 39, 2019, pp. 1730-1778

        

   47. I. H. Song, M. S. Jeong, H. J. Hong, J. I. Shin, Y. S. Park, S. K. Woo, B. S. Moon, K. I. Kim, Y. J. Lee, J. H. Kang, T. S. Lee. Development of a Theranostic Convergence Bioradiopharmaceutical for Immuno-PET Based Radioimmunotherapy of L1CAM in Cholangiocarcinoma Model

       Clin Cancer Res, vol. 25, 2019, pp. 6148-6159

        

   48. S. M. Srideshikan, J. Brooks, D. Zuro, B. Kumar, J. Sanchez, L. Echavarria Parra, M. Orellana, P. Vishwasrao, I. Nair, J. Chea, K. Poku, N. Bowles, A. Miller, T. Ebner, J. Molnar, J. Rosenthal, D. A. Vallera, J. Y. C. Wong, A. S. Stein, D. Colcher, J. E. Shively. ImmunoPET, ⁶⁴Cu-DOTA-Anti-CD33 PET-CT, Imaging of an AML Xenograft Model

       Clin Cancer Res, vol. 25, 2019, pp. 7463-7474

        

   49. T. A. R. Stallons, A. Saidi, I. Tworowska, E. S. Delpassand, J. J. Torgue, A. H. Staudacher, V. Liapis, W. Tieu, N. L. Wittwer, M. P. Brown. Preclinical Investigation of ²¹²Pb-DOTAMTATE for Peptide Receptor Radionuclide Therapy in a Neuroendocrine Tumor Model

       Mol Cancer Ther, vol. 18, 2019, pp. 1012-1021

        

   50. B. W. Stein, A. Morgenstern, E. R. Batista, E. R. Birnbaum, S. E. Bone, S. K. Cary, M. G. Ferrier, K. D. John, J. L. Pacheco, S. A. Kozimor, V. Mocko, B. L. Scott, P. Yang. Advancing Chelation Chemistry for Actinium and Other +3 f-Elements, Am, Cm, and La

       J Am Chem Soc, vol. 141, 2019, pp. 19404-19414

        

   51. H. Sudo, A. B. Tsuji, A. Sugyo, T. Saga, M. K. Kaneko, Y. Kato, T. Higashi. Therapeutic efficacy evaluation of radioimmunotherapy with (90) Y-labeled anti-podoplanin antibody NZ-12 for mesothelioma

       Cancer Sci, vol. 110, 2019, pp. 1653-1664

        

   52. D. L. J. Thorek, A. T. Ku, N. Mitsiades, D. Veach, P. A. Watson, D. Metha, S. E. Strand, S. K. Sharma, J. S. Lewis, D. S. Abou, H. G. Lilja, S. M. Larson, M. R. McDevitt, D. Ulmert. Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer

       Clin Cancer Res, vol. 25, 2019, pp. 881-891

        

   53. O. V. Timmermand, J. Elgqvist, K. A. Beattie, A. Örbom, E. Larsson, S. E. Eriksson, D. L. J. Thorek, B. J. Beattie, T. A. Tran, D. Ulmert, S. E. Strand. Preclinical efficacy of hK2 targeted [¹⁷⁷Lu]hu11B6 for prostate cancer theranostics

       Theranostics, vol. 9, 2019, pp. 2129-2142

        

   54. J. Wagner, M. A. Rapsomaniki, S. Chevrier, T. Anzeneder, C. Langwieder, A. Dykgers, M. Rees, A. Ramaswamy, S. Muenst, S. D. Soysal, A. Jacobs, J. Windhager, K. Silina, M. van den Broek, K. J. Dedes, M. Rodríguez Martínez, W. P. Weber, B. Bodenmiller. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer

       Cell, vol. 177, 2019, pp. 1330-1345.e18

        

   55. W. Wei, D. Jiang, Z. T. Rosenkrans, T. E. Barnhart, J. W. Engle, Q. Luo, W. Cai. HER2-targeted multimodal imaging of anaplastic thyroid cancer

       Am J Cancer Res, vol. 9, 2019, pp. 2413-2427

        

   56. S. K. Woo, S. J. Jang, M. J. Seo, J. H. Park, B. S. Kim, E. J. Kim, Y. J. Lee, T. S. Lee, G. I. An, I. H. Song, Y. Seo, K. I. Kim, J. H. Kang. Development of ⁶⁴Cu-NOTA-Trastuzumab for HER2 Targeting: A Radiopharmaceutical with Improved Pharmacokinetics for Human Studies

       J Nucl Med, vol. 60, 2019, pp. 26-33

        

   57. X. Xie, Y. Chen, Z. Chen, Y. Feng, J. Wang, T. Li, S. Li, X. Qin, C. Wu, C. Zheng, J. Zhu, F. You, Y. Liu, H. Yang. Polymeric Hybrid Nanomicelles for Cancer Theranostics: An Efficient and Precise Anticancer Strategy for the Codelivery of Doxorubicin/miR-34a and Magnetic Resonance Imaging

       ACS Appl Mater Interfaces, vol. 11, 2019, pp. 43865-43878

        

   58. C. Xu, J. Nam, H. Hong, Y. Xu, J. J. Moon. Positron Emission Tomography-Guided Photodynamic Therapy with Biodegradable Mesoporous Silica Nanoparticles for Personalized Cancer Immunotherapy

       ACS Nano, vol. 13, 2019, pp. 12148-12161

        

   59. H. Yakushiji, K. Kobayashi, F. Takenaka, Y. Kishi, M. Shinohara, M. Akehi, T. Sasaki, E. Ohno, E. Matsuura. Novel single-chain variant of antibody against mesothelin established by phage library

       Cancer Sci, vol. 110, 2019, pp. 2722-2733

        

   60. Z. Yang, Y. Dai, L. Shan, Z. Shen, Z. Wang, B. C. Yung, O. Jacobson, Y. Liu, W. Tang, S. Wang, L. Lin, G. Niu, P. Huang, X. Chen. Tumour microenvironment-responsive semiconducting polymer-based self-assembly nanotheranostics

       Nanoscale Horiz, vol. 4, 2019, pp. 426-433

        

2018

1. 1. I. S. Alam, A. T. Mayer, I. Sagiv-Barfi, K. Wang, O. Vermesh, D. K. Czerwinski, E. M. Johnson, M. L. James, R. Levy, S. S. Gambhir. Imaging activated T cells predicts response to cancer vaccines

      J Clin Invest, vol. 128, 2018, pp. 2569-2580

       

   2. M. E. Autenrieth, C. Seidl, F. Bruchertseifer, T. Horn, F. Kurtz, B. Feuerecker, C. D’Alessandria, C. Pfob, S. Nekolla, C. Apostolidis, S. Mirzadeh, J. E. Gschwend, M. Schwaiger, K. Scheidhauer, A. Morgenstern. Treatment of carcinoma in situ of the urinary bladder with an alpha-emitter immunoconjugate targeting the epidermal growth factor receptor: a pilot study

      Eur J Nucl Med Mol Imaging, vol. 45, 2018, pp. 1364-1371

       

   3. S. R. Banerjee, X. Song, X. Yang, I. Minn, A. Lisok, Y. Chen, A. Bui, S. Chatterjee, J. Chen, P. C. M. van Zijl, M. T. McMahon, M. G. Pomper. Salicylic Acid-Based Polymeric Contrast Agents for Molecular Magnetic Resonance Imaging of Prostate Cancer

      Chemistry, vol. 24, 2018, pp. 7235-7242

       

   4. I. J. G. Burvenich, S. Parakh, F. T. Lee, N. Guo, Z. Liu, H. K. Gan, A. Rigopoulos, G. J. O\’Keefe, S. J. Gong, Y. W. Goh, H. Tochon-Danguy, F. E. Scott, M. Kotsuma, K. Hirotani, G. Senaldi, A. M. Scott. Molecular imaging of T cell co-regulator factor B7-H3 with ⁸⁹Zr-DS-5573a

      Theranostics, vol. 8, 2018, pp. 4199-4209

       

   5. M. N. Centelles, M. Wright, P. W. So, M. Amrahli, X. Y. Xu, J. Stebbing, A. D. Miller, W. Gedroyc, M. Thanou. Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours

      J Control Release, vol. 280, 2018, pp. 87-98

       

   6. R. Chekol, V. R. Solomon, E. Alizadeh, W. Bernhard, D. Fisher, W. Hill, K. Barreto, J. F. DeCoteau, A. C. Parada, C. R. Geyer, H. Fonge. ⁸⁹Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I

      Oncotarget, vol. 9, 2018, pp. 17117-17132

       

   7. W. Chen, J. Dev, J. Mezhyrova, L. Pan, A. Piai, J. J. Chou. The Unusual Transmembrane Partition of the Hexameric Channel of the Hepatitis C Virus

      Structure, vol. 26, 2018, pp. 627-634.e4

       

   8. C. C. Cheng, K. F. Chou, C. W. Wu, N. W. Su, C. L. Peng, Y. W. Su, J. Chang, A. S. Ho, H. C. Lin, C. G. Chen, B. L. Yang, Y. C. Chang, Y. W. Chiang, K. H. Lim, Y. F. Chang. EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer

      Lung Cancer, vol. 116, 2018, pp. 80-89

       

   9. S. Chevrier, H. L. Crowell, V. R. T. Zanotelli, S. Engler, M. D. Robinson, B. Bodenmiller. Compensation of Signal Spillover in Suspension and Imaging Mass Cytometry

      Cell Syst, vol. 6, 2018, pp. 612-620.e5

       

   10. E. Deshayes, R. Ladjohounlou, P. Le Fur, A. Pichard, C. Lozza, V. Boudousq, S. Sevestre, M. Jarlier, R. Kashani, J. Koch, J. Sosabowski, J. Foster, N. Chouin, F. Bruchertseifer, A. Morgenstern, P. O. Kotzki, I. Navarro-Teulon, J. P. Pouget. Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer

       J Nucl Med, vol. 59, 2018, pp. 1234-1242

        

   11. X. Dong, W. Yin, X. Zhang, S. Zhu, X. He, J. Yu, J. Xie, Z. Guo, L. Yan, X. Liu, Q. Wang, Z. Gu, Y. Zhao. Intelligent MoS(2) Nanotheranostic for Targeted and Enzyme-/pH-/NIR-Responsive Drug Delivery To Overcome Cancer Chemotherapy Resistance Guided by PET Imaging

       ACS Appl Mater Interfaces, vol. 10, 2018, pp. 4271-4284

        

   12. D. Duan, H. Liu, Y. Xu, Y. Han, M. Xu, Z. Zhang, Z. Liu. Activating TiO(2) Nanoparticles: Gallium-68 Serves as a High-Yield Photon Emitter for Cerenkov-Induced Photodynamic Therapy

       ACS Appl Mater Interfaces, vol. 10, 2018, pp. 5278-5286

        

   13. H. M. Gibson, B. N. McKnight, A. Malysa, G. Dyson, W. N. Wiesend, C. E. McCarthy, J. Reyes, W. Z. Wei, N. T. Viola-Villegas. IFNγ PET Imaging as a Predictive Tool for Monitoring Response to Tumor Immunotherapy

       Cancer Res, vol. 78, 2018, pp. 5706-5717

        

   14. G. Han, M. H. Spitzer, S. C. Bendall, W. J. Fantl, G. P. Nolan. Metal-isotope-tagged monoclonal antibodies for high-dimensional mass cytometry

       Nat Protoc, vol. 13, 2018, pp. 2121-2148

        

   15. M. C. Hekman, M. Rijpkema, C. H. Muselaers, E. Oosterwijk, C. A. Hulsbergen-Van de Kaa, O. C. Boerman, W. J. Oyen, J. F. Langenhuijsen, P. F. Mulders. Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study

       Theranostics, vol. 8, 2018, pp. 2161-2170

        

   16. L. Henderson, O. Neumann, C. Kaffes, R. Zhang, V. Marangoni, M. K. Ravoori, V. Kundra, J. Bankson, P. Nordlander, N. J. Halas. Routes to Potentially Safer T(1) Magnetic Resonance Imaging Contrast in a Compact Plasmonic Nanoparticle with Enhanced Fluorescence

       ACS Nano, vol. 12, 2018, pp. 8214-8223

        

   17. K. E. Henry, T. R. Dilling, D. Abdel-Atti, K. J. Edwards, M. J. Evans, J. S. Lewis. Noninvasive ⁸⁹Zr-Transferrin PET Shows Improved Tumor Targeting Compared with (18)F-FDG PET in MYC-Overexpressing Human Triple-Negative Breast Cancer

       J Nucl Med, vol. 59, 2018, pp. 51-57

        

   18. A. I. Jensen, G. W. Severin, A. E. Hansen, F. P. Fliedner, R. Eliasen, L. Parhamifar, A. Kjær, T. L. Andresen, J. R. Henriksen. Remote-loading of liposomes with manganese-52 and in vivo evaluation of the stabilities of (52)Mn-DOTA and ⁶⁴Cu-DOTA using radiolabelled liposomes and PET imaging

       J Control Release, vol. 269, 2018, pp. 100-109

        

   19. S. K. Jones, K. Douglas, A. F. Shields, O. M. Merkel. Correlating quantitative tumor accumulation and gene knockdown using SPECT/CT and bioluminescence imaging within an orthotopic ovarian cancer model

       Biomaterials, vol. 178, 2018, pp. 183-192

        

   20. G. Kılıç, B. Osman, N. Tüzmen. Application of affinity microspheres for effective SPE cleanup before the determination of sulfamerazine by HPLC

       Mater Sci Eng C Mater Biol Appl, vol. 91, 2018, pp. 55-63

        

   21. H. Y. Kim, R. Li, T. S. C. Ng, G. Courties, C. B. Rodell, M. Prytyskach, R. H. Kohler, M. J. Pittet, M. Nahrendorf, R. Weissleder, M. A. Miller. Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using ⁶⁴Cu-Labeled Macrin

       ACS Nano, vol. 12, 2018, pp. 12015-12029

        

   22. J. Lai, D. Lu, C. Zhang, H. Zhu, L. Gao, Y. Wang, R. Bao, Y. Zhao, B. Jia, F. Wang, Z. Yang, Z. Liu. Noninvasive small-animal imaging of galectin-1 upregulation for predicting tumor resistance to radiotherapy

       Biomaterials, vol. 158, 2018, pp. 1-9

        

   23. H. Lajous, R. Riva, B. Lelièvre, C. Tétaud, S. Avril, F. Hindré, F. Boury, C. Jérôme, P. Lecomte, E. Garcion. Hybrid Gd(3+)/cisplatin cross-linked polymer nanoparticles enhance platinum accumulation and formation of DNA adducts in glioblastoma cell lines

       Biomater Sci, vol. 6, 2018, pp. 2386-2409

        

   24. Y. Li, Y. Du, X. Liang, T. Sun, H. Xue, J. Tian, Z. Jin. EGFR-targeted liposomal nanohybrid cerasomes: theranostic function and immune checkpoint inhibition in a mouse model of colorectal cancer

       Nanoscale, vol. 10, 2018, pp. 16738-16749

        

   25. N. Licciardello, S. Hunoldt, R. Bergmann, G. Singh, C. Mamat, A. Faramus, J. L. Z. Ddungu, S. Silvestrini, M. Maggini, L. De Cola, H. Stephan. Biodistribution studies of ultrasmall silicon nanoparticles and carbon dots in experimental rats and tumor mice

       Nanoscale, vol. 10, 2018, pp. 9880-9891

        

   26. L. Liu, Q. Chen, C. Ruan, X. Chen, Y. Zhang, X. He, Y. Zhang, Y. Lu, Q. Guo, T. Sun, H. Wang, C. Jiang. Platinum-Based Nanovectors Engineered with Immuno-Modulating Adjuvant for Inhibiting Tumor growth and Promoting Immunity

       Theranostics, vol. 8, 2018, pp. 2974-2987

        

   27. Y. Luo, E. H. Kim, C. A. Flask, H. A. Clark. Nanosensors for the Chemical Imaging of Acetylcholine Using Magnetic Resonance Imaging

       ACS Nano, vol. 12, 2018, pp. 5761-5773

        

   28. D. Mandikian, H. Rafidi, P. Adhikari, P. Venkatraman, L. Nazarova, G. Fung, I. Figueroa, G. Z. Ferl, S. Ulufatu, J. Ho, C. McCaughey, J. Lau, S. F. Yu, S. Prabhu, J. Sadowsky, C. A. Boswell. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging

       MAbs, vol. 10, 2018, pp. 1269-1280

        

   29. C. D. Martins, C. Da Pieve, T. A. Burley, R. Smith, D. M. Ciobota, L. Allott, K. J. Harrington, W. J. G. Oyen, G. Smith, G. Kramer-Marek. HER3-Mediated Resistance to Hsp90 Inhibition Detected in Breast Cancer Xenografts by Affibody-Based PET Imaging

       Clin Cancer Res, vol. 24, 2018, pp. 1853-1865

        

   30. K. E. Mayer, S. Mall, N. Yusufi, D. Gosmann, K. Steiger, L. Russelli, H. O. Bianchi, S. Audehm, R. Wagner, E. Bräunlein, A. Stelzl, F. Bassermann, W. Weichert, W. Weber, M. Schwaiger, C. D\’Alessandria, A. M. Krackhardt. T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target

       Theranostics, vol. 8, 2018, pp. 6070-6087

        

   31. V. R. N, H. S. Han, H. Lee, V. Q. Nguyen, S. Jeon, D. W. Jung, J. Lee, G. R. Yi, J. H. Park. ROS-responsive mesoporous silica nanoparticles for MR imaging-guided photodynamically maneuvered chemotherapy

       Nanoscale, vol. 10, 2018, pp. 9616-9627

        

   32. E. Pérez, K. Bierla, G. Grindlay, J. Szpunar, J. Mora, R. Lobinski. Lanthanide polymer labels for multiplexed determination of biomarkers in human serum samples by means of size exclusion chromatography-inductively coupled plasma mass spectrometry

       Anal Chim Acta, vol. 1018, 2018, pp. 7-15

        

   33. A. S. Pitek, H. Hu, S. Shukla, N. F. Steinmetz. Cancer Theranostic Applications of Albumin-Coated Tobacco Mosaic Virus Nanoparticles

       ACS Appl Mater Interfaces, vol. 10, 2018, pp. 39468-39477

        

   34. E. C. Pratt, T. M. Shaffer, Q. Zhang, C. M. Drain, J. Grimm. Nanoparticles as multimodal photon transducers of ionizing radiation

       Nat Nanotechnol, vol. 13, 2018, pp. 418-426

        

   35. M. Rabyk, A. Galisova, M. Jiratova, V. Patsula, L. Srbova, L. Loukotova, J. Parnica, D. Jirak, P. Stepanek, M. Hruby. Mannan-based conjugates as a multimodal imaging platform for lymph nodes

       J Mater Chem B, vol. 6, 2018, pp. 2584-2596

        

   36. F. Romero Pastrana, J. M. Thompson, M. Heuker, H. Hoekstra, C. A. Dillen, R. V. Ortines, A. G. Ashbaugh, J. E. Pickett, M. D. Linssen, N. M. Bernthal, K. P. Francis, G. Buist, M. van Oosten, G. M. van Dam, D. L. J. Thorek, L. S. Miller, J. M. van Dijl. Noninvasive optical and nuclear imaging of Staphylococcus-specific infection with a human monoclonal antibody-based probe

       Virulence, vol. 9, 2018, pp. 262-272

        

   37. T. H. Shin, S. Kang, S. Park, J. S. Choi, P. K. Kim, J. Cheon. A magnetic resonance tuning sensor for the MRI detection of biological targets

       Nat Protoc, vol. 13, 2018, pp. 2664-2684

        

   38. G. Sun, Y. Zhang, Y. Zhang, Z. Hu, Z. Xing, S. Zhang, X. Zhang. Ratiometric quantification of β2-microglobulin antigen in human serum based on elemental labeling strategy

       Talanta, vol. 189, 2018, pp. 249-253

        

   39. W. K. Tsai, K. A. Zettlitz, R. Tavaré, N. Kobayashi, R. E. Reiter, A. M. Wu. Dual-Modality ImmunoPET/Fluorescence Imaging of Prostate Cancer with an Anti-PSCA Cys-Minibody

       Theranostics, vol. 8, 2018, pp. 5903-5914

        

   40. G. A. Ulaner, S. K. Lyashchenko, C. Riedl, S. Ruan, P. B. Zanzonico, D. Lake, K. Jhaveri, B. Zeglis, J. S. Lewis, J. A. O\’Donoghue. First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using ⁸⁹Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer

       J Nucl Med, vol. 59, 2018, pp. 900-906

        

   41. T. van der Geest, D. M. Roeleveld, B. Walgreen, M. M. Helsen, T. K. Nayak, C. Klein, M. Hegen, G. Storm, J. M. Metselaar, W. B. van den Berg, P. M. van der Kraan, P. Laverman, O. C. Boerman, M. I. Koenders. Imaging fibroblast activation protein to monitor therapeutic effects of neutralizing interleukin-22 in collagen-induced arthritis

       Rheumatology (Oxford), vol. 57, 2018, pp. 737-747

        

   42. H. Yamada, M. Yamashita, H. Hayashi, M. Suzuki, N. Aratani. Semiconducting π-Extended Tetrathiafulvalene Derivatives

       Chemistry, vol. 24, 2018, pp. 18601-18612

        

   43. H. Yan, X. Gao, Y. Zhang, W. Chang, J. Li, X. Li, Q. Du, C. Li. Imaging Tiny Hepatic Tumor Xenografts via Endoglin-Targeted Paramagnetic/Optical Nanoprobe

       ACS Appl Mater Interfaces, vol. 10, 2018, pp. 17047-17057

        

   44. Q. Yin, L. Tang, K. Cai, X. Yang, L. Yin, Y. Zhang, L. W. Dobrucki, W. G. Helferich, T. M. Fan, J. Cheng. Albumin as a Trojan Horse for polymeric nanoconjugate transendothelial transport across tumor vasculatures for improved cancer targeting

       Biomater Sci, vol. 6, 2018, pp. 1189-1200

        

   45. J. T. Yoon, M. S. Longtine, B. V. Marquez-Nostra, R. L. Wahl. Evaluation of Next-Generation Anti-CD20 Antibodies Labeled with ⁸⁹Zr in Human Lymphoma Xenografts

       J Nucl Med, vol. 59, 2018, pp. 1219-1224

        

   46. Y. Yoshii, M. Yoshimoto, H. Matsumoto, H. Tashima, Y. Iwao, H. Takuwa, E. Yoshida, H. Wakizaka, T. Yamaya, M. R. Zhang, A. Sugyo, S. Hanadate, A. B. Tsuji, T. Higashi. Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with ⁶⁴Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts

       Oncotarget, vol. 9, 2018, pp. 28935-28950

        

   47. Y. Zhang, G. Sun, Y. Zhang, B. Huang, Z. Xing, S. Zhang, X. Zhang. Simultaneous competitive and sandwich formats multiplexed immunoassays based on ICP-MS detection

       Talanta, vol. 185, 2018, pp. 237-242

        

2014

1. 1. A. G. Terwisscha van Scheltinga, P. Berghuis, H. H. Nienhuis, H. Timmer-Bosscha, L. Pot, S. B. Gaykema, M. N. Lub-de Hooge, J. G. Kosterink, E. G. de Vries, C. P. Schröder. Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer

      Eur J Cancer, vol. 50, 2014, pp. 2508-16

       

2011

1. 1. W. B. Nagengast, M. N. Hooge, E. M. van Straten, S. Kruijff, A. H. Brouwers, W. F. den Dunnen, J. R. de Jong, H. Hollema, R. A. Dierckx, N. H. Mulder, E. G. de Vries, H. J. Hoekstra, G. A. Hospers. VEGF-SPECT with ¹¹¹In-bevacizumab in stage III/IV melanoma patients

      Eur J Cancer, vol. 47, 2011, pp. 1595-602

       

2000

1. 1. Lara L. Chappell, Kim A. Deal, Ekaterina Dadachova, and Martin W. Brechbiel. Synthesis, Conjugation, and Radiolabeling of a Novel Bifunctional Chelating Agent for 225Ac Radioimmunotherapy Applications

      Bioconjugate Chem., vol. 11, 2000, pp. 510-519, doi: 10.1021/bc990153f

       

1999

1. Kim A. Deal, Ila A. Davis, Saed Mirzadeh, Stephen J. Kennel, Martin W. Brechbiel. Improved in Vivo Stability of Actinium-225 Macrocyclic Complexes

   , 1999, pp. 2988-2992, doi: 10.1021/jm990141f